NCT06193915

Brief Summary

This study will investigate the effectiveness of analgesia of ultrasound hematoma block compared to 'blind' hematoma block in patients with dislocated distal radius fracture.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 21, 2023

Completed
4 months until next milestone

First Posted

Study publicly available on registry

January 5, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

January 5, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

March 19, 2024

Status Verified

March 1, 2024

Enrollment Period

11 months

First QC Date

September 21, 2023

Last Update Submit

March 16, 2024

Conditions

Keywords

Distal radius fractureUltrasoundHematoma block

Outcome Measures

Primary Outcomes (1)

  • Effectiveness of analgesia during closed reduction of a distal radius fracture

    Pain reduction will be measured on a Numeric Rating Scale( NRS-scale; 0-10) at different moments

    NRS before, during and after (10-15 min) injection of hematoma block, NRS-score during closed reduction and after closed reduction (5 min)

Secondary Outcomes (11)

  • Number of participants in which hematoma was aspirated during hematoma block

    During hematoma block

  • Procedural time of the Hematoma block

    Time from insertion of the needle until needle is withdrawn out of the patient (up to maximum of 30 min.)

  • Procedural time of the reduction

    From moment physician is ready to start the reduction until cast is applied (up to maximum of 30 min.)

  • Satisfaction of the HB provided by physician performing the HB procedure

    10-15 minutes after hematoma block

  • Satisfaction of reduction provided by physician performing reduction measured

    10-15 minutes after closed reduction

  • +6 more secondary outcomes

Study Arms (2)

Ultrasound guided hematoma block

EXPERIMENTAL

Patients in this group will receive ultrasound guided hematoma block before reduction of their dislocated distal radius fracture.

Device: Ultrasound guided hematoma block.

Blind hematoma block

ACTIVE COMPARATOR

Patients in this group will receive standard treatment; hematoma block with palpation of the fracture site (blind hematoma block)

Procedure: Blind hematoma block

Interventions

Patients with a dislocated fracture of the distal radius will receive ultrasound guided hematoma block with 10mL lidocaine 2% to get real-time guidance of the given anesthesia into the fracture site before closed reduction of a distal radius fracture.

Ultrasound guided hematoma block

Patients with a distal radius fracture will receive standard treatment; hematoma block with 10mL 2% lidocaine performed with palpation of the fracture site (blind hematoma block) before closed reduction of dislocated distal radius fractures.

Blind hematoma block

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 16 years
  • Confirmed fracture of the distal radius requiring closed reduction, defined as any off the following items(7):
  • \>10 degrees of dorsal angulation;
  • \>20 degrees of volar angulation;
  • \>2 mm step-off intra-articular;
  • \>3 mm radial shortening;
  • \>15 degrees radial inclination;
  • Translation and non-intact radio-carpal alignment in the lateral view
  • Significant translation in the posterior-anterior(PA)-view.

You may not qualify if:

  • No informed consent can be given (cognitive impairment, severe dementia, no knowledge of Dutch language e.a.)
  • Neurovascular compromise or open fractures requiring (immediate) surgery or reduction.
  • First reduction already performed
  • Multi-trauma patients requiring other urgent procedures/tests or with respiratory or hemodynamical compromise
  • Pre-existent osteosynthesis material in situ in the affected arm
  • Skin injury (with exception of minor abrasions), local infection or recent burns hindering or contra-indicating the use of ultrasound and ultrasound gel
  • Allergy for local anesthetics

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medisch Centrum Leeuwarden

Leeuwarden, Provincie Friesland, 8934AD, Netherlands

RECRUITING

MeSH Terms

Conditions

Wrist FracturesFracture Dislocation

Condition Hierarchy (Ancestors)

Wrist InjuriesArm InjuriesWounds and InjuriesFractures, BoneJoint DislocationsJoint DiseasesMusculoskeletal Diseases

Study Officials

  • Pieter Veenstra

    Medisch Centrum Leeuwarden

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Because treatment in both groups are different (one group with and one group without ultrasound) it's not possible to mask the treating physician for the intervention.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

September 21, 2023

First Posted

January 5, 2024

Study Start

January 5, 2024

Primary Completion

December 1, 2024

Study Completion

December 1, 2024

Last Updated

March 19, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations